GBM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Inovio Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.557 EUR -25.08%

Market Cap: €38.3m

	Inovio Pharmaceuticals Inc F:GBM	US
A	American States Water Co XMUN:FDK	US
M	MLP SE XMUN:MLP	DE
	Dingdong (Cayman) Ltd NYSE:DDL	CN
S	Spearmint Resources Inc XHAM:SQH	CA
P	Prudential PLC XMUN:PRU	UK
	Mcphy Energy SA PAR:ALMCP	FR
X	Xiamen International Port Co Ltd F:XRG	CN
	Mitsui Chemicals Inc F:MSI	JP
M	Marchex Inc F:NHM	US
T	TechTarget Inc F:EFT	US
S	Siam Wellness Group PCL SET:SPA	TH
G	Gibraltar Industries Inc F:GI2	US
	Spearmint Resources Inc F:SQH	CA
	Lanson BCC SA PAR:ALLAN	FR

Profitability Summary

Inovio Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-45.463%

Low Net Margin

Negative 3Y Average Net Margin

-44.925%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-44.203%

Negative ROE

-296%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-638%

ROIC is Increasing

-1.045% > -713%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.